Title slide
description
Transcript of Title slide
Title slideGeorgia Hospital Engagement Network
Healthcare Acquired Condition Affinity GroupJune 19, 2013
Presenter: Dr. Teresa Pounds, PharmD, BCNSP
Moderator: Tracy Rutland, RT(R), MBA/MHA HAC Affinity Lead
ANTICOAGULATION PERFORMANCE
IMPROVEMENT INITIATIVES
Dr. Teresa Pounds, PharmD, BCNSP
ObjectiveShare strategies employed at AMC to
decrease international normalized ratio - INR related adverse drug events – ADE via the following:
Information Technology (IT)Efficient Utilization of Pharmacy
ResourcesConcurrent INR MonitoringPatient Safety Committee
Involvement
BackgroundAtlanta Medical Center has been successful in its ability to avoid adverse drug events (ADE) associated with the use of anticoagulants such as warfarin.
Due to the dedication of the pharmacy department in ensuring that patient safety is prioritized first while providing the best pharmaceutical care to its patients.
Points For Discussion Information Technology (IT)
Efficient Utilization of Pharmacy Resources
Concurrent INR Monitoring
Patient Safety Committee Involvement
2- Year Snapshot
Information Technology (IT)Pharmacy collaborated with IT to
generate a daily INR reportINR > 4 report
Report automatically prints first thing in the morning
INR drill down Involves the investigation of INRs > 3 Outpatient vs inpatient incident of elevated
INR Appropriate induction dose of warfarin Drug/food associated interactions
Daily INR Report
Efficient Utilization of Pharmacy Resources Decentralized clinical pharmacists
Performs INR drill down Intervenes where necessary
Pharmacy residents Performs INR drill down Intervenes where necessary
4-yr students Performs INR drill down Reports the information to a decentralized
clinical pharmacist and pharmacy resident
Concurrent INR monitoringClinical pharmacist at point of
order entry and pharmacy residents
Ensures the ordering of initial INR prior to warfarin
Daily INR monitoring of patients on warfarin 4-th year pharmacy students perform these as
well Appropriate intervention as indicated
Concurrent INR Monitoring cont’dStaff education on improved
methods of counseling the warfarin patientuse of warfarin teaching guidepresence of pyxis prompts ensure
that nurses verify patients INR prior warfarin administration
Reporting StructureAnticoagulation subcommittee
co-chaired by Dr. Pounds with representatives such as : PhysiciansNursesPharmacistsDietitiansRisk managementIT
Reporting Structure cont’dPatient Safety Committee (PSC)
Ensures accountability amongst parties responsible for daily INR monitoring
Monthly report sent to PSC PI indicators
RESULTSTotal Percent (%) of Patients achieving super-therapeutic INR levels (>4) while receiving warfarin (Coumadin®) therapy (Goal: <5)
AUGUSTSEPTEMBER0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00% 5.30%
2.74%2.40% 2.50%
20102012